NeurologyLive, CMSC to Offer 2 Educational Webcast Programs in Multiple Sclerosis

October 2, 2020

SAP Partner

The free webcast programs, which will focus on cannabis use in MS and MS nursing care, will earn participants up to 3 CE credits each.

NeurologyLive, in partnership with the Consortium of Multiple Sclerosis Centers (CMSC) and the International Organization for Multiple Sclerosis Nurses (IOMSN), is pleased to announce 2 upcoming webcast programs on multiple sclerosis (MS) taking place in October.

The “Differing Perspectives on Multiple Sclerosis Nursing Care” and “Cannabis and MS: Helping Patients Understand Risks and Benefits” live virtual webinar programs will address key knowledge gaps across the provider and patient communities.

The October programs will feature the following interactive virtual webcasts:

  • Differing Perspectives on Multiple Sclerosis Care: Nursing and Patient Programs

A 2-part webcast series geared toward MS nursing professionals and patients. The first session for MS nursing professionals will take place on Saturday, October 10, from 9AM to 12PM Noon EDT, followed by a complimentary patient program from 12:30PM to 2:30PM EDT. The featured speakers are Denise Bruen, ANP-BC, MSN, MSCN; Stephanie Agrella, PhDc, MSN, RN, ANP-BC, MSCN; and Marie Namey, APRN, MSCN. This innovative program will provide nurses and patients with evidence-based information on the latest disease-modifying therapies, as well as symptoms and the psychological impact of MS, in order to educate and improve the relationships between MS nursing professionals and their patients. Nursing professionals will earn 3 CE credits for completing the nursing program. To register, click here.

  • Cannabis and MS: Helping Patients Understand Risks and Benefits

This progressive, 3-part webcast series will take place on Wednesday, October 14, 21, and 28, at 7PM EDT. The featured speaker is Allen C. Bowling, MD, PhD, director of the NeuroHealth Institute and clinical professor of neurology at the University of Colorado. During this series, Bowling will describe the current understanding of pharmacology, efficacy, and adverse events associated with cannabis use in MS, including drug interactions, the role of the FDA, and MS clinical trial data, among other topics. Participants will earn 1 CE credit for completing each session. To register, click here.